Comparison of effects of rabeprazole sodium SAWAI 10 mg and Pariet 10mg tablets on acid secretion using 24-hour gastric pH monitoring

Comparison of effects of rabeprazole sodium SAWAI 10 mg and Pariet 10mg tablets on acid secretion using 24-hour gastric pH monitoring - Comparison of rabeprazole sodium SAWAI 10 mg and pariet tablets by gastric pH monitoring

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003837

Enrollment

Registered

2010-06-29

Start date

2010-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

A group: Execution on June 30. End August 5 in day B group: Execution on July 2. End August 7 in day

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1. Japanese healthy male volunteers with ages of 20-35 years 2. Body weight 55-85 kg 3. BMI(body mass index) of 18.5- 25.0 (less than 25.0) 4 Nonsmoker or ex-smoker 5 H.pylori IgG antibody negative

Exclusion criteria

Exclusion criteria: 1. History of major gut operations. 2. Hypersensitivity, allergy, and idiosyncrasy, to drugs

Design outcomes

Primary

Measure	Time frame
24-hour gastric pH monitoring data.	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026